The Effect of Intercostal Nerve Block With Dexamethasone and Ropivacaine on Rebound Pain After Thoracoscopic Surgery

Launched by BEIJING TIANTAN HOSPITAL · Apr 11, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how a specific treatment called an intercostal nerve block, combined with two medications (dexamethasone and ropivacaine), can help reduce rebound pain after thoracoscopic surgery. Rebound pain is a sudden increase in pain that some patients experience after the initial pain relief from the nerve block wears off. This study aims to see if adding dexamethasone can make a difference in reducing this rebound pain and improving recovery for patients.

To participate in the trial, individuals must be over 18 years old and scheduled for elective thoracoscopic surgery. However, there are some important criteria that may exclude potential participants, such as having bleeding disorders, allergies to local anesthetics, severe heart or lung conditions, or certain other health issues. Participants will receive the nerve block treatment and will be monitored for pain levels during their recovery. This trial is not yet recruiting, so interested individuals should keep an eye out for updates.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients scheduled for elective thoracoscopic surgery Age \> 18 years old ASA ⅰ-ⅲ Informed consent was signed
• Exclusion Criteria:
• • Patients with aoagulation disorders Patients with allergy to local anesthetics Patients with severe cardiopulmonary diseases Patients had systemic steroid use Patients with chronic pain Patients with uncontrolled diabetes and mental disorders History of drug abuse; Body Mass Index more than 35 kg.m-2 Pregnant or breastfeeding woman.